Selected article for: "blood cell and RBC red blood cell"

Author: Sengupta, Prattusha; Mahalakshmi, Vijayaraghavan; Stebin, Justus Jijo; Ganesh, Subhadra; Suganya, Natarajan; Chatterjee, Suvro
Title: Nitric oxide donors offer protection to RBC from storage lesion.
  • Cord-id: vx8uxqmt
  • Document date: 2020_8_4
  • ID: vx8uxqmt
    Snippet: BACKGROUND Red blood cell (RBC) which is the most commonly transfused blood component due to its ability to save a life in absence of any other blood components can be stored up to maximum 6 weeks by following standard preservation procedure. During storage, RBC undergoes various biophysical and biochemical changes (commonly known as storage lesion) for which blood transfusion with "old RBC" shows a lot of clinical problems especially relevant to critically ill patients. Recent research on S-nit
    Document: BACKGROUND Red blood cell (RBC) which is the most commonly transfused blood component due to its ability to save a life in absence of any other blood components can be stored up to maximum 6 weeks by following standard preservation procedure. During storage, RBC undergoes various biophysical and biochemical changes (commonly known as storage lesion) for which blood transfusion with "old RBC" shows a lot of clinical problems especially relevant to critically ill patients. Recent research on S-nitrosylation of haemoglobin to improve oxygen delivery of banked blood revealed the important role of nitric oxide (NO) in protecting storage lesion. MATERIALS AND METHODS In the present study, we used various "NO donating" chemicals with different NO release dynamics and chemistries in RBC storage cocktails to test the effects of NO on storage lesion. Changes in different storage markers were evaluated after 7 days storage of pre-treated RBC. RESULTS All the NO donors have shown protection against hemolysis. However, S-nitroso glutathione (GSNO) ranks first in shielding RBCs from storage lesion and additionally it helps in elevating the value of 2, 3-di phosphoglycerate (2, 3-DPG), improving the RBC membrane fluidity and decreasing the adhesion towards endothelial monolayer. DISCUSSION Present study reveals that NO released from NO donors confers protection against storage lesions of the RBC. Further, the study confirms that pre-treatment with GSNO, a NO donor and a nitrosylating agent, ensures the best protection to RBC during low temperature storage, when compared to other NO donor treatments.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1
    Co phrase search for related documents, hyperlinks ordered by date